(-0.01%) 5 331.25 points
(-0.03%) 39 933 points
(-0.10%) 18 744 points
(-0.80%) $79.16
(0.44%) $2.76
(-0.83%) $2 418.30
(-1.90%) $31.81
(-2.18%) $1 040.50
(-0.02%) $0.921
(-0.24%) $10.67
(-0.01%) $0.787
(-0.29%) $90.41
@ $2.18
Utstedt: 14 feb 2024 @ 20:06
Avkastning: -62.40%
Forrige signal: feb 13 - 21:42
Forrige signal:
Avkastning: 3.82 %
Live Chart Being Loaded With Signals
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases...
Stats | |
---|---|
Dagens volum | 2.24M |
Gjennomsnittsvolum | 2.98M |
Markedsverdi | 88.80M |
EPS | $0 ( 2024-05-09 ) |
Neste inntjeningsdato | ( $-0.320 ) 2024-06-17 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.660 |
ATR14 | $0.00400 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-15 | Allen Andrew R | Buy | 47 873 | Common Stock |
2024-05-16 | Allen Andrew R | Sell | 24 263 | Common Stock |
2024-05-15 | Allen Andrew R | Buy | 615 000 | Stock Option (Right to Buy) |
2024-05-15 | Jones Erin | Buy | 27 128 | Common Stock |
2024-05-16 | Jones Erin | Sell | 13 749 | Common Stock |
INSIDER POWER |
---|
96.52 |
Last 98 transactions |
Buy: 7 577 348 | Sell: 147 493 |
Volum Korrelasjon
Gritstone Oncology Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
LULU | 0.893 |
EZGO | 0.89 |
ATNF | 0.887 |
AFYA | 0.87 |
SRNE | 0.863 |
QH | 0.862 |
ISSC | 0.861 |
RCMT | 0.856 |
ATRC | 0.855 |
YI | 0.854 |
10 Mest negative korrelasjoner | |
---|---|
LABP | -0.936 |
NVEI | -0.921 |
CURI | -0.918 |
CENX | -0.918 |
IDN | -0.916 |
TH | -0.909 |
PAYS | -0.908 |
VFF | -0.898 |
WIRE | -0.898 |
STOK | -0.893 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Gritstone Oncology Inc Korrelasjon - Valuta/Råvare
Gritstone Oncology Inc Økonomi
Annual | 2023 |
Omsetning: | $1.33M |
Bruttogevinst: | $-6.26M (-470.32 %) |
EPS: | $-1.200 |
FY | 2023 |
Omsetning: | $1.33M |
Bruttogevinst: | $-6.26M (-470.32 %) |
EPS: | $-1.200 |
FY | 2022 |
Omsetning: | $9.27M |
Bruttogevinst: | $-6.42M (-69.28 %) |
EPS: | $-1.240 |
FY | 2021 |
Omsetning: | $48.21M |
Bruttogevinst: | $48.21M (100.00 %) |
EPS: | $-0.965 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Gritstone Oncology Inc
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.